Rain Therapeutics Inc.
News
Pathos AI Completes Acquisition of Rain Oncology
Business Wire Pathos AI, Inc. (Pathos) today announced that it has, through its wholly owned subsidiary WK Merger Sub, Inc. (Merger Sub), successfully completed its tender offer to acquire all outstanding shares...\n more…
Rain Therapeutics Enters Merger with Pathos AI Despite Legal Hurdles
TipRanks Financial Blog Rain Therapeutics (RAIN) has released an update. Rain Oncology Inc. entered into a Merger Agreement on December 13, 2023, with Pathos AI, Inc. and its subsidiary, W...\n more…
Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has obtained a Fair Price in its transaction with Pathos
PR Newswire Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has obtained a Fair Price in its transaction with Pathos Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has...\n more…
RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders
Business Wire Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Rain Oncology Inc. (NASDAQ: RAIN) to Pathos AI, Inc. for $1.16 in cash per share plus a non-tradeable contingent...\n more…
